AlphaCrest Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,687
Closed -$690K 518
2022
Q3
$690K Sell
10,687
-28,269
-73% -$1.96M 0.04% 820
2022
Q2
$2.7M Buy
38,956
+15,878
+69% +$1.18M 0.13% 194
2022
Q1
$1.77M Sell
23,078
-12,077
-34% -$868K 0.1% 282
2021
Q4
$2.69M Sell
35,155
-5,951
-14% -$437K 0.1% 278
2021
Q3
$3.03M Buy
41,106
+17,451
+74% +$1.31M 0.16% 151
2021
Q2
$1.58M Sell
23,655
-2,539
-10% -$170K 0.07% 461
2021
Q1
$1.95M Buy
26,194
+10,209
+64% +$775K 0.11% 261
2020
Q4
$1.16M Buy
15,985
+11,098
+227% +$783K 0.1% 269
2020
Q3
$325K Sell
4,887
-10,872
-69% -$688K 0.04% 816
2020
Q2
$898K Sell
15,759
-54,045
-77% -$2.65M 0.15% 179
2020
Q1
$2.45M Buy
69,804
+60,612
+659% +$2.89M 0.3% 42
2019
Q4
$480K Sell
9,192
-37,053
-80% -$1.84M 0.04% 813
2019
Q3
$2.33M Buy
46,245
+1,780
+4% +$87.6K 0.14% 179
2019
Q2
$2.13M Buy
44,465
+32,197
+262% +$1.49M 0.18% 135
2019
Q1
$594K Buy
+12,268
New +$553K 0.09% 394

Other funds holding HOLX

AlphaCrest Capital Management's HOLX Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Hologic (HOLX) in Q4 2022, closing a stake of 10,687 shares — an estimated $690K sold.

AlphaCrest Capital Management first reported a position in HOLX in Q1 2019 and held it in 15 quarters. The position peaked at $3.03M in Q3 2021. 698 funds tracked by Wall St. Rank hold HOLX as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Hologic position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 10,687 Hologic shares in Q4 2022, an estimated $690K.
  • AlphaCrest Capital Management first reported a position in Hologic in Q1 2019 and held it in 15 quarters.
  • AlphaCrest Capital Management's Hologic position peaked at $3.03M in Q3 2021.
  • 698 funds tracked by Wall St. Rank held Hologic as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.